Description

The global medical cannabis market is poised to grow by US$ 5.5 billion from 2022 to 2028, registering a CAGR of 9.8% during the forecast period, according to StrategyHelix.

The report provides up-to-date market size data for period 2018-2021 and forecast to 2028 covering key market aspects like sales value for medical cannabis. The global medical cannabis market is segmented on the basis of product, derivative, route of administration, application, distribution channel, and region. By product, the global medical cannabis market has been segmented into dissolvables and powders, oils, ointments and creams, solids. In 2021, the dissolvables and powders segment made up the largest share of revenue generated by the medical cannabis market. Based upon derivative, the global medical cannabis market is categorized into cannabidiol, tetrahydrocannabinol. On the basis of route of administration, the global medical cannabis market has been segmented into inhalation, oral, topical. By application, the global medical cannabis market has been segmented into management of neurological disorders, mental health, pain management. Based on distribution channel, the global medical cannabis market is categorized into hospitals, online pharmacies, pharmacies. In terms of geography, the global medical cannabis market has been segmented into North America, Europe, Asia-Pacific, Rest of the World.

The global medical cannabis market is highly competitive. Some of the leading companies operating in the market are Aurora Cannabis Inc., Cannabis Sativa Inc., Canopy Growth Corporation, Cara Therapeutics Inc., Emerald Health Therapeutics Inc., GB Sciences Inc., GW Pharmaceuticals plc, InterCure Ltd., Medical Marijuana Inc., Tilray Brands Inc.

The report is an invaluable resource for companies and organizations active in this industry. It provides a cohesive picture of the medical cannabis market to help drive informed decision making for industry executives, policy makers, academic, and analysts.

Report Scope

Product: dissolvables and powders, oils, ointments and creams, solids
Derivative: cannabidiol, tetrahydrocannabinol
Route of administration: inhalation, oral, topical
Application: management of neurological disorders, mental health, pain management
Distribution channel: hospitals, online pharmacies, pharmacies
Region: North America, Europe, Asia-Pacific, Rest of the World
Years considered: this report covers the period 2018 to 2028

Key Benefits for Stakeholders

– Get a comprehensive picture of the global medical cannabis market
– Identify regional strategies and strategic priorities on the basis of local data
– Pinpoint growth sectors and trends for investment

Table of Contents

Part 1. Introduction
– Scope of the study
– Study period
– Geographical scope
– Research methodology
Part 2. Medical cannabis market overview
Part 3. Market breakdown by product
– Dissolvables and powders
– Oils
– Ointments and creams
– Solids
Part 4. Market breakdown by derivative
– Cannabidiol
– Tetrahydrocannabinol
Part 5. Market breakdown by route of administration
– Inhalation
– Oral
– Topical
Part 6. Market breakdown by application
– Management of neurological disorders
– Mental health
– Pain management
Part 7. Market breakdown by distribution channel
– Hospitals
– Online pharmacies
– Pharmacies
Part 8. Market breakdown by region
– North America
– Europe
– Asia-Pacific
– Rest of the World
Part 9. Key companies
– Aurora Cannabis Inc.
– Cannabis Sativa, Inc.
– Canopy Growth Corporation
– Cara Therapeutics, Inc.
– Emerald Health Therapeutics, Inc.
– GB Sciences, Inc.
– GW Pharmaceuticals plc
– InterCure Ltd.
– Medical Marijuana, Inc.
– Tilray Brands, Inc.
About StrategyHelix
Disclaimer